skip to Main Content

Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.

​The objective of the present study was to describe a new model of the cost-effectiveness of treatment of generalized anxiety disorder (GAD) and its application to a comparison of pregabalin versus venlafaxine extended-release (XR) from a Spanish healthcare perspective. Microsimulation techniques, including Hamilton Anxiety Scale (HAM-A) score, number of weeks with minimal or no anxiety (HAM-A

Authors: Vera-Llonch M; Dukes E; Rejas J; Sofrygin O; Mychaskiw M; Oster G

​Eur J Health Econ. 2010 Feb;11(1):35-44. doi: 10.1007/s10198-009-0160-7. Epub 2009 Jun 9.

PubMed abstract

Explore all studies and publications

Back To Top